EARLY VIROLOGICAL RESPONSE IS THE MAIN PREDICTOR OF VIRAL ERADICATION IN HCV HAEMODIALYSIS PATIENTS TREATED WITH PEGYLATED INTERFERON PLUS RIBAVIRIN

被引：0
|
作者：
Rendina, M. [1 ]
Tucci, A. [1 ]
Castellaneta, A. [1 ]
Castellaneta, N. M. [1 ]
Chiala', C. [1 ]
Leandro, G. [2 ]
Gesualdo, L. [3 ]
Di Leo, A. [1 ]
机构：
[1] Univ Hosp, Gastroenterol & Digest Endoscopy, Bari, Italy
[2] IRCCS Castellana Grotte, Div Gastroenterol, Castellana Grotte, Italy
[3] Univ Hosp, Nephrol & Dialysis, Bari, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2014年 / 46卷
关键词：
D O I：
10.1016/S1590-8658(14)60033-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC.04.6
引用
收藏
页码：S12 / S13
页数：2
相关论文
共 50 条
  • [31] Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients
    Helal, Gouda Kamel
    Gad, Magdy Abdelmawgoud
    Abd-Ellah, Mohamed Fahmy
    Eid, Mahmoud Saied
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (12) : 2170 - 2178
  • [32] Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C
    Breilh, D.
    Foucher, J.
    Castera, L.
    Trimoulet, P.
    Djabarouti, S.
    Merrouche, W.
    Couzigou, P.
    Saux, M. -C.
    De Ledinghen, V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (05) : 487 - 494
  • [33] HCV-1 subtypes and response to pegylated interferon plus ribavirin therapy
    Alberti, A.
    Colombo, M.
    Craxi, A.
    Piccinino, F.
    Rizzetto, M.
    Sarracino, M.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S132 - S132
  • [34] Early HCV-RNA clearance in HIV/HCV-coinfected patients treated with pegylated interferon alfa-2a plus ribavirin
    Camino, N
    Nuñez, M
    Romero, M
    Barreiro, P
    Ocampo, A
    Miralles, C
    Martín-Carbonero, L
    Fernández, A
    García-Samaniego, J
    Soriano, V
    HEPATOLOGY, 2004, 40 (04) : 402A - 403A
  • [35] Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study
    Kovari, Helen
    Russmann, Stefan
    Ledergerber, Bruno
    Mueller, Daniel
    Rotger, Margalida
    Velli, Pablo
    Cavassini, Matthias
    Ambrosioni, Juan
    Bregenzer, Andrea
    Stoeckle, Marcel
    Bernasconi, Enos
    Rauch, Andri
    Speck, Roberto F.
    PLOS ONE, 2015, 10 (07):
  • [36] The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon
    Marucco, D. Aguilar
    de Requena, D. Gonzalez
    Bonora, S.
    Tettoni, C.
    Bonasso, M.
    De Blasi, T.
    D'Avolio, A.
    Sciandra, M.
    Siccardi, M.
    Baietto, L.
    Trentini, L.
    Sinicco, A.
    Cariti, G.
    Di Perri, G.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (04) : 919 - 924
  • [37] Hcv dynamics in HIV/HCV coinfected patients treated with pegylated interferon and ribavirin.
    Talal, AH
    Shata, MT
    Flynn, SM
    Dorante, G
    Laughlin, M
    Ribeiro, RM
    Perelson, AS
    HEPATOLOGY, 2002, 36 (04) : 205A - 205A
  • [38] Early Virological Response with Consensus Interferon and Ribavirin in HCV Genotype 3 Non-Responders and Relapsers to Pegylated Interferon Based Therapy
    Shakir, Tanzila
    Abbas, Zaigham
    Memon, Sadik
    Tayyab, Ghias
    Shaikh, Kashif
    Nasir, Bilal
    Hassan, Ghias
    Subhan, Amna
    Hamid, Saeed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S122 - S123
  • [39] Might rapid virological response be used as a stopping rule in liver transplant recipients treated with pegylated interferon plus ribavirin?
    Donato, Maria Francesca
    Agnelli, Francesca
    Rigamonti, Cristina
    Arosio, Eliana
    Colombo, Massimo
    LIVER TRANSPLANTATION, 2008, 14 (09) : 1383 - 1384
  • [40] Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin
    Laufer, Natalia
    Laguno, Montserrat
    Perez, Inaki
    Cifuentes, Carmen
    Murillas, Javier
    Vidal, Francesc
    Bonet, Lucia
    Veloso, Sergio
    Maria Gatell, Jose
    Mallolas, Josep
    ANTIVIRAL THERAPY, 2008, 13 (07) : 953 - 957
12345